This suggested that BMP9 ameliorates NAFLD not only by improving lipid and glucose metabolism but also via decreasing macrophage infiltration and inflammation in mouse livers. The gene discussed is GDF2; the disease is metabolic dysfunction-associated steatotic liver disease.